BS

Bikash Shaw

Director Designated Partner DIN 06605314
DIN 06605314 First appointment Jun 2013 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 2013
Shareholding value •••• Premium profile

About Bikash Shaw

Data last updated:

Bikash Shaw was a Designated Partner at Riel Pharma Llp (2021–2022) and Director at Finapolis Micro Credit Association (2013–2014). The companies operate in Chemicals and Financial Services.

DIN 06605314
Primary Designation Designated Partner
Industry Chemicals
First Appointment 17 Jun 2013

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Riel Pharma Llp AAW-9985
Designated Partner13 May 20212021Active
Finapolis Micro Credit Association U65920MP2013NPL030561
Director17 Jun 20132013Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Riel Pharma Llp
Finapolis Micro Credit Association
Premium access

Shareholding and investment profile for Bikash Shaw

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bikash Shaw

Bikash Shaw was first appointed on 17 Jun 2013 as Director at Finapolis Micro Credit Association. The most recent appointment on record is 13 May 2021 at Riel Pharma Llp.

Bikash Shaw held 2 earlier board appointments: Riel Pharma Llp (Designated Partner, 13 May 2021 to 26 Dec 2022); Finapolis Micro Credit Association (Director, 17 Jun 2013 to 15 May 2014).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available